tirzepatide and allodynia In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist semaglutide in 5-23% of recipients Do GLP-1 Medications Increase Pain

Frontiers in Endocrinology, 12 , 666687

1 2 3 4 5 6 7 8 9 10 11 12 13 "Depakote- divalproex sodium tablet, delayed release"

The findings are based on an online survey of 16,946 US adults conducted by the data analytics firm Gallup in the first three quarters of 2025

All doses above are reported from published research protocols using laboratory subjects

Safety and evidence level: what is and isnt known In the mouse obesity study, systemic administration of the NNMT inhibitor reduced body weight, white-adipose mass and plasma cholesterol without changing food intake and without any observable adverse effects over the study period